PMC:7546716 / 6467-9661
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T97","span":{"begin":19,"end":24},"obj":"Body_part"},{"id":"T98","span":{"begin":51,"end":55},"obj":"Body_part"},{"id":"T99","span":{"begin":158,"end":160},"obj":"Body_part"},{"id":"T100","span":{"begin":240,"end":242},"obj":"Body_part"},{"id":"T101","span":{"begin":264,"end":269},"obj":"Body_part"},{"id":"T102","span":{"begin":346,"end":348},"obj":"Body_part"},{"id":"T103","span":{"begin":409,"end":414},"obj":"Body_part"},{"id":"T104","span":{"begin":553,"end":558},"obj":"Body_part"},{"id":"T105","span":{"begin":590,"end":594},"obj":"Body_part"},{"id":"T106","span":{"begin":691,"end":700},"obj":"Body_part"},{"id":"T107","span":{"begin":760,"end":765},"obj":"Body_part"},{"id":"T108","span":{"begin":807,"end":812},"obj":"Body_part"},{"id":"T109","span":{"begin":977,"end":981},"obj":"Body_part"},{"id":"T110","span":{"begin":1007,"end":1009},"obj":"Body_part"},{"id":"T111","span":{"begin":1041,"end":1046},"obj":"Body_part"},{"id":"T112","span":{"begin":1104,"end":1108},"obj":"Body_part"},{"id":"T113","span":{"begin":1104,"end":1106},"obj":"Body_part"},{"id":"T114","span":{"begin":1123,"end":1138},"obj":"Body_part"},{"id":"T115","span":{"begin":1133,"end":1138},"obj":"Body_part"},{"id":"T116","span":{"begin":1181,"end":1183},"obj":"Body_part"},{"id":"T117","span":{"begin":1274,"end":1279},"obj":"Body_part"},{"id":"T118","span":{"begin":1311,"end":1313},"obj":"Body_part"},{"id":"T119","span":{"begin":1317,"end":1319},"obj":"Body_part"},{"id":"T120","span":{"begin":1380,"end":1385},"obj":"Body_part"},{"id":"T121","span":{"begin":1463,"end":1468},"obj":"Body_part"},{"id":"T122","span":{"begin":1490,"end":1492},"obj":"Body_part"},{"id":"T123","span":{"begin":1667,"end":1672},"obj":"Body_part"},{"id":"T124","span":{"begin":1771,"end":1782},"obj":"Body_part"},{"id":"T125","span":{"begin":1813,"end":1815},"obj":"Body_part"},{"id":"T126","span":{"begin":1831,"end":1835},"obj":"Body_part"},{"id":"T127","span":{"begin":1831,"end":1833},"obj":"Body_part"},{"id":"T128","span":{"begin":1840,"end":1842},"obj":"Body_part"},{"id":"T129","span":{"begin":1857,"end":1872},"obj":"Body_part"},{"id":"T130","span":{"begin":1867,"end":1872},"obj":"Body_part"},{"id":"T131","span":{"begin":1900,"end":1904},"obj":"Body_part"},{"id":"T132","span":{"begin":1974,"end":1977},"obj":"Body_part"},{"id":"T133","span":{"begin":1988,"end":2002},"obj":"Body_part"},{"id":"T134","span":{"begin":1997,"end":2002},"obj":"Body_part"},{"id":"T135","span":{"begin":2158,"end":2163},"obj":"Body_part"},{"id":"T136","span":{"begin":2181,"end":2190},"obj":"Body_part"},{"id":"T137","span":{"begin":2191,"end":2202},"obj":"Body_part"},{"id":"T138","span":{"begin":2218,"end":2222},"obj":"Body_part"},{"id":"T139","span":{"begin":2218,"end":2220},"obj":"Body_part"},{"id":"T140","span":{"begin":2225,"end":2227},"obj":"Body_part"},{"id":"T141","span":{"begin":2236,"end":2238},"obj":"Body_part"},{"id":"T142","span":{"begin":2242,"end":2246},"obj":"Body_part"},{"id":"T143","span":{"begin":2242,"end":2244},"obj":"Body_part"},{"id":"T144","span":{"begin":2249,"end":2251},"obj":"Body_part"},{"id":"T145","span":{"begin":2256,"end":2258},"obj":"Body_part"},{"id":"T146","span":{"begin":2266,"end":2268},"obj":"Body_part"},{"id":"T147","span":{"begin":2336,"end":2341},"obj":"Body_part"},{"id":"T148","span":{"begin":2368,"end":2373},"obj":"Body_part"},{"id":"T149","span":{"begin":2411,"end":2416},"obj":"Body_part"},{"id":"T150","span":{"begin":2427,"end":2429},"obj":"Body_part"},{"id":"T151","span":{"begin":2440,"end":2443},"obj":"Body_part"},{"id":"T152","span":{"begin":2457,"end":2460},"obj":"Body_part"},{"id":"T153","span":{"begin":2512,"end":2521},"obj":"Body_part"},{"id":"T154","span":{"begin":2522,"end":2533},"obj":"Body_part"},{"id":"T155","span":{"begin":2549,"end":2558},"obj":"Body_part"},{"id":"T156","span":{"begin":2583,"end":2592},"obj":"Body_part"},{"id":"T157","span":{"begin":2618,"end":2627},"obj":"Body_part"},{"id":"T158","span":{"begin":2647,"end":2656},"obj":"Body_part"},{"id":"T159","span":{"begin":2685,"end":2692},"obj":"Body_part"},{"id":"T160","span":{"begin":2723,"end":2726},"obj":"Body_part"},{"id":"T161","span":{"begin":2727,"end":2738},"obj":"Body_part"},{"id":"T162","span":{"begin":2739,"end":2749},"obj":"Body_part"},{"id":"T163","span":{"begin":2777,"end":2779},"obj":"Body_part"},{"id":"T164","span":{"begin":2780,"end":2791},"obj":"Body_part"},{"id":"T165","span":{"begin":2821,"end":2825},"obj":"Body_part"},{"id":"T166","span":{"begin":2874,"end":2881},"obj":"Body_part"},{"id":"T167","span":{"begin":2957,"end":2964},"obj":"Body_part"},{"id":"T168","span":{"begin":3176,"end":3193},"obj":"Body_part"},{"id":"T169","span":{"begin":3189,"end":3193},"obj":"Body_part"}],"attributes":[{"id":"A97","pred":"fma_id","subj":"T97","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A98","pred":"fma_id","subj":"T98","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A99","pred":"fma_id","subj":"T99","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A100","pred":"fma_id","subj":"T100","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A101","pred":"fma_id","subj":"T101","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A102","pred":"fma_id","subj":"T102","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A103","pred":"fma_id","subj":"T103","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A104","pred":"fma_id","subj":"T104","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A105","pred":"fma_id","subj":"T105","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A106","pred":"fma_id","subj":"T106","obj":"http://purl.org/sig/ont/fma/fma241981"},{"id":"A107","pred":"fma_id","subj":"T107","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A108","pred":"fma_id","subj":"T108","obj":"http://purl.org/sig/ont/fma/fma68877"},{"id":"A109","pred":"fma_id","subj":"T109","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A110","pred":"fma_id","subj":"T110","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A111","pred":"fma_id","subj":"T111","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A112","pred":"fma_id","subj":"T112","obj":"http://purl.org/sig/ont/fma/fma84051"},{"id":"A113","pred":"fma_id","subj":"T113","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A114","pred":"fma_id","subj":"T114","obj":"http://purl.org/sig/ont/fma/fma273565"},{"id":"A115","pred":"fma_id","subj":"T115","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A116","pred":"fma_id","subj":"T116","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A117","pred":"fma_id","subj":"T117","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A118","pred":"fma_id","subj":"T118","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A119","pred":"fma_id","subj":"T119","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A120","pred":"fma_id","subj":"T120","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A121","pred":"fma_id","subj":"T121","obj":"http://purl.org/sig/ont/fma/fma68877"},{"id":"A122","pred":"fma_id","subj":"T122","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A123","pred":"fma_id","subj":"T123","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A124","pred":"fma_id","subj":"T124","obj":"http://purl.org/sig/ont/fma/fma63261"},{"id":"A125","pred":"fma_id","subj":"T125","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A126","pred":"fma_id","subj":"T126","obj":"http://purl.org/sig/ont/fma/fma84051"},{"id":"A127","pred":"fma_id","subj":"T127","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A128","pred":"fma_id","subj":"T128","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A129","pred":"fma_id","subj":"T129","obj":"http://purl.org/sig/ont/fma/fma273565"},{"id":"A130","pred":"fma_id","subj":"T130","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A131","pred":"fma_id","subj":"T131","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A132","pred":"fma_id","subj":"T132","obj":"http://purl.org/sig/ont/fma/fma20935"},{"id":"A133","pred":"fma_id","subj":"T133","obj":"http://purl.org/sig/ont/fma/fma70572"},{"id":"A134","pred":"fma_id","subj":"T134","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A135","pred":"fma_id","subj":"T135","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A136","pred":"fma_id","subj":"T136","obj":"http://purl.org/sig/ont/fma/fma62864"},{"id":"A137","pred":"fma_id","subj":"T137","obj":"http://purl.org/sig/ont/fma/fma63261"},{"id":"A138","pred":"fma_id","subj":"T138","obj":"http://purl.org/sig/ont/fma/fma86583"},{"id":"A139","pred":"fma_id","subj":"T139","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A140","pred":"fma_id","subj":"T140","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A141","pred":"fma_id","subj":"T141","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A142","pred":"fma_id","subj":"T142","obj":"http://purl.org/sig/ont/fma/fma86583"},{"id":"A143","pred":"fma_id","subj":"T143","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A144","pred":"fma_id","subj":"T144","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A145","pred":"fma_id","subj":"T145","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A146","pred":"fma_id","subj":"T146","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A147","pred":"fma_id","subj":"T147","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A148","pred":"fma_id","subj":"T148","obj":"http://purl.org/sig/ont/fma/fma68877"},{"id":"A149","pred":"fma_id","subj":"T149","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A150","pred":"fma_id","subj":"T150","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A151","pred":"fma_id","subj":"T151","obj":"http://purl.org/sig/ont/fma/fma20935"},{"id":"A152","pred":"fma_id","subj":"T152","obj":"http://purl.org/sig/ont/fma/fma20935"},{"id":"A153","pred":"fma_id","subj":"T153","obj":"http://purl.org/sig/ont/fma/fma62864"},{"id":"A154","pred":"fma_id","subj":"T154","obj":"http://purl.org/sig/ont/fma/fma63261"},{"id":"A155","pred":"fma_id","subj":"T155","obj":"http://purl.org/sig/ont/fma/fma241981"},{"id":"A156","pred":"fma_id","subj":"T156","obj":"http://purl.org/sig/ont/fma/fma241981"},{"id":"A157","pred":"fma_id","subj":"T157","obj":"http://purl.org/sig/ont/fma/fma241981"},{"id":"A158","pred":"fma_id","subj":"T158","obj":"http://purl.org/sig/ont/fma/fma241981"},{"id":"A159","pred":"fma_id","subj":"T159","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A160","pred":"fma_id","subj":"T160","obj":"http://purl.org/sig/ont/fma/fma20935"},{"id":"A161","pred":"fma_id","subj":"T161","obj":"http://purl.org/sig/ont/fma/fma62854"},{"id":"A162","pred":"fma_id","subj":"T162","obj":"http://purl.org/sig/ont/fma/fma63261"},{"id":"A163","pred":"fma_id","subj":"T163","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A164","pred":"fma_id","subj":"T164","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A165","pred":"fma_id","subj":"T165","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A166","pred":"fma_id","subj":"T166","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A167","pred":"fma_id","subj":"T167","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A168","pred":"fma_id","subj":"T168","obj":"http://purl.org/sig/ont/fma/fma84070"},{"id":"A169","pred":"fma_id","subj":"T169","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Both ILC2 and γδ T cells are centrally involved in lung homoeostasis and are rapidly activated in response to pathogens including viruses;19, 21 in COVID-19, IL-4 is upregulated at early stages and in milder forms of the disease,10 whereas IL-9 and activated γδ T cells are observed more frequently in mild-to-moderate disease,9, 22 and IFNγ and IL-17 progressively increase with disease severity.6 Vγ9Vδ2+ T cells from patients with COVID-19 have been found to express an effector memory phenotype three times more frequently than do conventional αβ T cells,23 thus suggesting that this T cell subset is selectively stimulated in COVID-19. Because of significantly higher expression of the chemokine receptor CXCR3 compared with their αβ counterparts,24 γδ T cells might be rapidly recruited into inflamed lungs of patients with COVID-19 in response to the observed strong upregulation of the CXCR3 ligands CXCL9 and CXCL10 (figure 1 ).6, 9, 11, 15, 25, 26, 27, 28\nFigure 1 T-cell polarisation in COVID-19\nIL-33 released from virus-damaged cells might induce dysregulated GATA3+Foxp3+ Tregs and promote IL-2 production by dendritic cells, resulting in further expansion of Tregs. IL-33 might also elicit differentiation of ILC2, with TGFβ enhancing ST2 expression on these cells and facilitating production of IL-9. IL-9 in turn stimulates expansion of effector memory Vγ9Vδ2+ T cells with mixed Th1 and Th17 profiles that express CXCR3 and are recruited to the lungs by CXCL9 and CXCL10. IL-9 possibly induces its own transcription factor PU.1 and thus act in an autocrine and paracrine manner (along with TGFβ) to drive proliferation and survival of ILC2 and γδ T cells. Additional positive loops might be fed by IFNγ, which triggers production of CXCL9 and CXCL10 by macrophages. In severe forms of COVID-19, IL-33, along with IL-2 and IL-7 released by dendritic cells, might further stimulate T-cell expansion through STAT5 and induce production of large amounts of GM-CSF by γδ and T helper cells. At advanced stages of disease, aberrant activation of the MyD88-related NF-κB pathway and activation of the NLRP3 inflammasome might induce virus-exposed cells and infiltrating monocytes–macrophages to overproduce IL-1β, IL-23, and IL-6. IL-1β, IL-23, IL-6, and IL-7 act on STAT3 and RORC, thus promoting differentiation of CCR2+ T cells that are recruited to the lungs by CCL2 and CCL8 into γδT17 and Th17 cells producing IL-17 and GM-CSF. In turn, GM-CSF might further recruit and activate proinflammatory monocytes–macrophages. CCR=C-C motif chemokine receptor. CCL=C-C motif chemokine ligand. CXCL=C-X-C motif chemokine ligand. CXCR=C-X-C chemokine receptor. Foxp=forkhead box protein. GATA=GATA-binding factor. GM-CSF=granulocyte-macrophage colony-stimulating factor. IL=interleukin. ILC2=type 2 innate lymphoid cell. MyD88=myeloid differentiation primary response protein. NF-κB=nuclear factor-kappa B. NLRP=NACHT, LRR, and PYD domains-containing protein. PU.1=transcription factor PU.1. RORC=nuclear receptor ROR-gamma. ST2=ST2 receptor. STAT=signal transducer and transcription activator. TGF=transforming growth factor. Th=T-helper. TLR=toll-like receptors. Treg=regulatory T cell."}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T9","span":{"begin":51,"end":55},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"uberon_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Both ILC2 and γδ T cells are centrally involved in lung homoeostasis and are rapidly activated in response to pathogens including viruses;19, 21 in COVID-19, IL-4 is upregulated at early stages and in milder forms of the disease,10 whereas IL-9 and activated γδ T cells are observed more frequently in mild-to-moderate disease,9, 22 and IFNγ and IL-17 progressively increase with disease severity.6 Vγ9Vδ2+ T cells from patients with COVID-19 have been found to express an effector memory phenotype three times more frequently than do conventional αβ T cells,23 thus suggesting that this T cell subset is selectively stimulated in COVID-19. Because of significantly higher expression of the chemokine receptor CXCR3 compared with their αβ counterparts,24 γδ T cells might be rapidly recruited into inflamed lungs of patients with COVID-19 in response to the observed strong upregulation of the CXCR3 ligands CXCL9 and CXCL10 (figure 1 ).6, 9, 11, 15, 25, 26, 27, 28\nFigure 1 T-cell polarisation in COVID-19\nIL-33 released from virus-damaged cells might induce dysregulated GATA3+Foxp3+ Tregs and promote IL-2 production by dendritic cells, resulting in further expansion of Tregs. IL-33 might also elicit differentiation of ILC2, with TGFβ enhancing ST2 expression on these cells and facilitating production of IL-9. IL-9 in turn stimulates expansion of effector memory Vγ9Vδ2+ T cells with mixed Th1 and Th17 profiles that express CXCR3 and are recruited to the lungs by CXCL9 and CXCL10. IL-9 possibly induces its own transcription factor PU.1 and thus act in an autocrine and paracrine manner (along with TGFβ) to drive proliferation and survival of ILC2 and γδ T cells. Additional positive loops might be fed by IFNγ, which triggers production of CXCL9 and CXCL10 by macrophages. In severe forms of COVID-19, IL-33, along with IL-2 and IL-7 released by dendritic cells, might further stimulate T-cell expansion through STAT5 and induce production of large amounts of GM-CSF by γδ and T helper cells. At advanced stages of disease, aberrant activation of the MyD88-related NF-κB pathway and activation of the NLRP3 inflammasome might induce virus-exposed cells and infiltrating monocytes–macrophages to overproduce IL-1β, IL-23, and IL-6. IL-1β, IL-23, IL-6, and IL-7 act on STAT3 and RORC, thus promoting differentiation of CCR2+ T cells that are recruited to the lungs by CCL2 and CCL8 into γδT17 and Th17 cells producing IL-17 and GM-CSF. In turn, GM-CSF might further recruit and activate proinflammatory monocytes–macrophages. CCR=C-C motif chemokine receptor. CCL=C-C motif chemokine ligand. CXCL=C-X-C motif chemokine ligand. CXCR=C-X-C chemokine receptor. Foxp=forkhead box protein. GATA=GATA-binding factor. GM-CSF=granulocyte-macrophage colony-stimulating factor. IL=interleukin. ILC2=type 2 innate lymphoid cell. MyD88=myeloid differentiation primary response protein. NF-κB=nuclear factor-kappa B. NLRP=NACHT, LRR, and PYD domains-containing protein. PU.1=transcription factor PU.1. RORC=nuclear receptor ROR-gamma. ST2=ST2 receptor. STAT=signal transducer and transcription activator. TGF=transforming growth factor. Th=T-helper. TLR=toll-like receptors. Treg=regulatory T cell."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T57","span":{"begin":148,"end":156},"obj":"Disease"},{"id":"T58","span":{"begin":434,"end":442},"obj":"Disease"},{"id":"T59","span":{"begin":631,"end":639},"obj":"Disease"},{"id":"T60","span":{"begin":830,"end":838},"obj":"Disease"},{"id":"T61","span":{"begin":998,"end":1006},"obj":"Disease"},{"id":"T62","span":{"begin":1803,"end":1811},"obj":"Disease"},{"id":"T63","span":{"begin":2535,"end":2542},"obj":"Disease"}],"attributes":[{"id":"A57","pred":"mondo_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A58","pred":"mondo_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A59","pred":"mondo_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A60","pred":"mondo_id","subj":"T60","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A61","pred":"mondo_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A62","pred":"mondo_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A63","pred":"mondo_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/MONDO_0007763"}],"text":"Both ILC2 and γδ T cells are centrally involved in lung homoeostasis and are rapidly activated in response to pathogens including viruses;19, 21 in COVID-19, IL-4 is upregulated at early stages and in milder forms of the disease,10 whereas IL-9 and activated γδ T cells are observed more frequently in mild-to-moderate disease,9, 22 and IFNγ and IL-17 progressively increase with disease severity.6 Vγ9Vδ2+ T cells from patients with COVID-19 have been found to express an effector memory phenotype three times more frequently than do conventional αβ T cells,23 thus suggesting that this T cell subset is selectively stimulated in COVID-19. Because of significantly higher expression of the chemokine receptor CXCR3 compared with their αβ counterparts,24 γδ T cells might be rapidly recruited into inflamed lungs of patients with COVID-19 in response to the observed strong upregulation of the CXCR3 ligands CXCL9 and CXCL10 (figure 1 ).6, 9, 11, 15, 25, 26, 27, 28\nFigure 1 T-cell polarisation in COVID-19\nIL-33 released from virus-damaged cells might induce dysregulated GATA3+Foxp3+ Tregs and promote IL-2 production by dendritic cells, resulting in further expansion of Tregs. IL-33 might also elicit differentiation of ILC2, with TGFβ enhancing ST2 expression on these cells and facilitating production of IL-9. IL-9 in turn stimulates expansion of effector memory Vγ9Vδ2+ T cells with mixed Th1 and Th17 profiles that express CXCR3 and are recruited to the lungs by CXCL9 and CXCL10. IL-9 possibly induces its own transcription factor PU.1 and thus act in an autocrine and paracrine manner (along with TGFβ) to drive proliferation and survival of ILC2 and γδ T cells. Additional positive loops might be fed by IFNγ, which triggers production of CXCL9 and CXCL10 by macrophages. In severe forms of COVID-19, IL-33, along with IL-2 and IL-7 released by dendritic cells, might further stimulate T-cell expansion through STAT5 and induce production of large amounts of GM-CSF by γδ and T helper cells. At advanced stages of disease, aberrant activation of the MyD88-related NF-κB pathway and activation of the NLRP3 inflammasome might induce virus-exposed cells and infiltrating monocytes–macrophages to overproduce IL-1β, IL-23, and IL-6. IL-1β, IL-23, IL-6, and IL-7 act on STAT3 and RORC, thus promoting differentiation of CCR2+ T cells that are recruited to the lungs by CCL2 and CCL8 into γδT17 and Th17 cells producing IL-17 and GM-CSF. In turn, GM-CSF might further recruit and activate proinflammatory monocytes–macrophages. CCR=C-C motif chemokine receptor. CCL=C-C motif chemokine ligand. CXCL=C-X-C motif chemokine ligand. CXCR=C-X-C chemokine receptor. Foxp=forkhead box protein. GATA=GATA-binding factor. GM-CSF=granulocyte-macrophage colony-stimulating factor. IL=interleukin. ILC2=type 2 innate lymphoid cell. MyD88=myeloid differentiation primary response protein. NF-κB=nuclear factor-kappa B. NLRP=NACHT, LRR, and PYD domains-containing protein. PU.1=transcription factor PU.1. RORC=nuclear receptor ROR-gamma. ST2=ST2 receptor. STAT=signal transducer and transcription activator. TGF=transforming growth factor. Th=T-helper. TLR=toll-like receptors. Treg=regulatory T cell."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T81","span":{"begin":17,"end":24},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T82","span":{"begin":51,"end":55},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T83","span":{"begin":51,"end":55},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T84","span":{"begin":85,"end":94},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T85","span":{"begin":130,"end":137},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T86","span":{"begin":249,"end":258},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T87","span":{"begin":262,"end":269},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T88","span":{"begin":330,"end":332},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T89","span":{"begin":407,"end":414},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T90","span":{"begin":551,"end":558},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T91","span":{"begin":588,"end":594},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T92","span":{"begin":758,"end":765},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T93","span":{"begin":807,"end":812},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T94","span":{"begin":943,"end":945},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T95","span":{"begin":959,"end":961},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T96","span":{"begin":975,"end":981},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T97","span":{"begin":1027,"end":1032},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T98","span":{"begin":1041,"end":1046},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T99","span":{"begin":1073,"end":1078},"obj":"http://purl.obolibrary.org/obo/CLO_0053477"},{"id":"T100","span":{"begin":1079,"end":1084},"obj":"http://purl.obolibrary.org/obo/PR_000001350"},{"id":"T101","span":{"begin":1086,"end":1091},"obj":"http://purl.obolibrary.org/obo/CL_0000792"},{"id":"T102","span":{"begin":1104,"end":1108},"obj":"http://purl.obolibrary.org/obo/PR_000001379"},{"id":"T103","span":{"begin":1123,"end":1138},"obj":"http://purl.obolibrary.org/obo/CL_0000451"},{"id":"T104","span":{"begin":1174,"end":1179},"obj":"http://purl.obolibrary.org/obo/CL_0000792"},{"id":"T105","span":{"begin":1250,"end":1253},"obj":"http://purl.obolibrary.org/obo/CLO_0051025"},{"id":"T106","span":{"begin":1274,"end":1279},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T107","span":{"begin":1378,"end":1385},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T108","span":{"begin":1463,"end":1468},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T109","span":{"begin":1520,"end":1545},"obj":"http://purl.obolibrary.org/obo/PR_000001944"},{"id":"T110","span":{"begin":1665,"end":1672},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T111","span":{"begin":1831,"end":1835},"obj":"http://purl.obolibrary.org/obo/PR_000001379"},{"id":"T112","span":{"begin":1857,"end":1872},"obj":"http://purl.obolibrary.org/obo/CL_0000451"},{"id":"T113","span":{"begin":1898,"end":1904},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T114","span":{"begin":1988,"end":2002},"obj":"http://purl.obolibrary.org/obo/CL_0000912"},{"id":"T115","span":{"begin":2044,"end":2054},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T116","span":{"begin":2080,"end":2081},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T117","span":{"begin":2094,"end":2104},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T118","span":{"begin":2144,"end":2149},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T119","span":{"begin":2158,"end":2163},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T120","span":{"begin":2181,"end":2190},"obj":"http://purl.obolibrary.org/obo/CL_0000576"},{"id":"T121","span":{"begin":2334,"end":2341},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T122","span":{"begin":2368,"end":2373},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T123","span":{"begin":2398,"end":2401},"obj":"http://purl.obolibrary.org/obo/CLO_0050389"},{"id":"T124","span":{"begin":2411,"end":2416},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T125","span":{"begin":2487,"end":2495},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T126","span":{"begin":2512,"end":2521},"obj":"http://purl.obolibrary.org/obo/CL_0000576"},{"id":"T127","span":{"begin":2608,"end":2611},"obj":"http://purl.obolibrary.org/obo/CLO_0009645"},{"id":"T128","span":{"begin":2608,"end":2611},"obj":"http://purl.obolibrary.org/obo/CLO_0050824"},{"id":"T129","span":{"begin":2643,"end":2646},"obj":"http://purl.obolibrary.org/obo/CLO_0009645"},{"id":"T130","span":{"begin":2643,"end":2646},"obj":"http://purl.obolibrary.org/obo/CLO_0050824"},{"id":"T131","span":{"begin":2805,"end":2825},"obj":"http://purl.obolibrary.org/obo/CL_0001065"},{"id":"T132","span":{"begin":2887,"end":2888},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T133","span":{"begin":2910,"end":2911},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T134","span":{"begin":2971,"end":2996},"obj":"http://purl.obolibrary.org/obo/PR_000001944"},{"id":"T135","span":{"begin":3031,"end":3034},"obj":"http://purl.obolibrary.org/obo/CLO_0051025"},{"id":"T136","span":{"begin":3035,"end":3038},"obj":"http://purl.obolibrary.org/obo/CLO_0051025"},{"id":"T137","span":{"begin":3054,"end":3060},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T138","span":{"begin":3090,"end":3099},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T139","span":{"begin":3171,"end":3175},"obj":"http://purl.obolibrary.org/obo/CL_0000792"},{"id":"T140","span":{"begin":3176,"end":3193},"obj":"http://purl.obolibrary.org/obo/CL_0000815"}],"text":"Both ILC2 and γδ T cells are centrally involved in lung homoeostasis and are rapidly activated in response to pathogens including viruses;19, 21 in COVID-19, IL-4 is upregulated at early stages and in milder forms of the disease,10 whereas IL-9 and activated γδ T cells are observed more frequently in mild-to-moderate disease,9, 22 and IFNγ and IL-17 progressively increase with disease severity.6 Vγ9Vδ2+ T cells from patients with COVID-19 have been found to express an effector memory phenotype three times more frequently than do conventional αβ T cells,23 thus suggesting that this T cell subset is selectively stimulated in COVID-19. Because of significantly higher expression of the chemokine receptor CXCR3 compared with their αβ counterparts,24 γδ T cells might be rapidly recruited into inflamed lungs of patients with COVID-19 in response to the observed strong upregulation of the CXCR3 ligands CXCL9 and CXCL10 (figure 1 ).6, 9, 11, 15, 25, 26, 27, 28\nFigure 1 T-cell polarisation in COVID-19\nIL-33 released from virus-damaged cells might induce dysregulated GATA3+Foxp3+ Tregs and promote IL-2 production by dendritic cells, resulting in further expansion of Tregs. IL-33 might also elicit differentiation of ILC2, with TGFβ enhancing ST2 expression on these cells and facilitating production of IL-9. IL-9 in turn stimulates expansion of effector memory Vγ9Vδ2+ T cells with mixed Th1 and Th17 profiles that express CXCR3 and are recruited to the lungs by CXCL9 and CXCL10. IL-9 possibly induces its own transcription factor PU.1 and thus act in an autocrine and paracrine manner (along with TGFβ) to drive proliferation and survival of ILC2 and γδ T cells. Additional positive loops might be fed by IFNγ, which triggers production of CXCL9 and CXCL10 by macrophages. In severe forms of COVID-19, IL-33, along with IL-2 and IL-7 released by dendritic cells, might further stimulate T-cell expansion through STAT5 and induce production of large amounts of GM-CSF by γδ and T helper cells. At advanced stages of disease, aberrant activation of the MyD88-related NF-κB pathway and activation of the NLRP3 inflammasome might induce virus-exposed cells and infiltrating monocytes–macrophages to overproduce IL-1β, IL-23, and IL-6. IL-1β, IL-23, IL-6, and IL-7 act on STAT3 and RORC, thus promoting differentiation of CCR2+ T cells that are recruited to the lungs by CCL2 and CCL8 into γδT17 and Th17 cells producing IL-17 and GM-CSF. In turn, GM-CSF might further recruit and activate proinflammatory monocytes–macrophages. CCR=C-C motif chemokine receptor. CCL=C-C motif chemokine ligand. CXCL=C-X-C motif chemokine ligand. CXCR=C-X-C chemokine receptor. Foxp=forkhead box protein. GATA=GATA-binding factor. GM-CSF=granulocyte-macrophage colony-stimulating factor. IL=interleukin. ILC2=type 2 innate lymphoid cell. MyD88=myeloid differentiation primary response protein. NF-κB=nuclear factor-kappa B. NLRP=NACHT, LRR, and PYD domains-containing protein. PU.1=transcription factor PU.1. RORC=nuclear receptor ROR-gamma. ST2=ST2 receptor. STAT=signal transducer and transcription activator. TGF=transforming growth factor. Th=T-helper. TLR=toll-like receptors. Treg=regulatory T cell."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T71","span":{"begin":158,"end":160},"obj":"Chemical"},{"id":"T73","span":{"begin":240,"end":242},"obj":"Chemical"},{"id":"T75","span":{"begin":346,"end":348},"obj":"Chemical"},{"id":"T77","span":{"begin":473,"end":481},"obj":"Chemical"},{"id":"T78","span":{"begin":900,"end":907},"obj":"Chemical"},{"id":"T79","span":{"begin":908,"end":913},"obj":"Chemical"},{"id":"T80","span":{"begin":918,"end":924},"obj":"Chemical"},{"id":"T81","span":{"begin":1007,"end":1009},"obj":"Chemical"},{"id":"T83","span":{"begin":1104,"end":1106},"obj":"Chemical"},{"id":"T85","span":{"begin":1181,"end":1183},"obj":"Chemical"},{"id":"T87","span":{"begin":1311,"end":1313},"obj":"Chemical"},{"id":"T89","span":{"begin":1317,"end":1319},"obj":"Chemical"},{"id":"T91","span":{"begin":1354,"end":1362},"obj":"Chemical"},{"id":"T92","span":{"begin":1472,"end":1477},"obj":"Chemical"},{"id":"T93","span":{"begin":1482,"end":1488},"obj":"Chemical"},{"id":"T94","span":{"begin":1490,"end":1492},"obj":"Chemical"},{"id":"T96","span":{"begin":1751,"end":1756},"obj":"Chemical"},{"id":"T97","span":{"begin":1761,"end":1767},"obj":"Chemical"},{"id":"T98","span":{"begin":1813,"end":1815},"obj":"Chemical"},{"id":"T100","span":{"begin":1831,"end":1833},"obj":"Chemical"},{"id":"T102","span":{"begin":1840,"end":1842},"obj":"Chemical"},{"id":"T104","span":{"begin":1971,"end":1973},"obj":"Chemical"},{"id":"T105","span":{"begin":2076,"end":2078},"obj":"Chemical"},{"id":"T108","span":{"begin":2218,"end":2220},"obj":"Chemical"},{"id":"T110","span":{"begin":2225,"end":2227},"obj":"Chemical"},{"id":"T112","span":{"begin":2236,"end":2238},"obj":"Chemical"},{"id":"T114","span":{"begin":2242,"end":2244},"obj":"Chemical"},{"id":"T116","span":{"begin":2249,"end":2251},"obj":"Chemical"},{"id":"T118","span":{"begin":2256,"end":2258},"obj":"Chemical"},{"id":"T120","span":{"begin":2266,"end":2268},"obj":"Chemical"},{"id":"T122","span":{"begin":2427,"end":2429},"obj":"Chemical"},{"id":"T124","span":{"begin":2437,"end":2439},"obj":"Chemical"},{"id":"T125","span":{"begin":2454,"end":2456},"obj":"Chemical"},{"id":"T126","span":{"begin":2569,"end":2572},"obj":"Chemical"},{"id":"T127","span":{"begin":2593,"end":2599},"obj":"Chemical"},{"id":"T128","span":{"begin":2628,"end":2634},"obj":"Chemical"},{"id":"T129","span":{"begin":2685,"end":2692},"obj":"Chemical"},{"id":"T130","span":{"begin":2720,"end":2722},"obj":"Chemical"},{"id":"T131","span":{"begin":2777,"end":2779},"obj":"Chemical"},{"id":"T133","span":{"begin":2874,"end":2881},"obj":"Chemical"},{"id":"T134","span":{"begin":2883,"end":2885},"obj":"Chemical"},{"id":"T137","span":{"begin":2957,"end":2964},"obj":"Chemical"},{"id":"T138","span":{"begin":3024,"end":3029},"obj":"Chemical"},{"id":"T139","span":{"begin":3133,"end":3135},"obj":"Chemical"}],"attributes":[{"id":"A71","pred":"chebi_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A72","pred":"chebi_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A73","pred":"chebi_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A74","pred":"chebi_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A75","pred":"chebi_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A76","pred":"chebi_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A77","pred":"chebi_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/CHEBI_35224"},{"id":"A78","pred":"chebi_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/CHEBI_52214"},{"id":"A79","pred":"chebi_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/CHEBI_138154"},{"id":"A80","pred":"chebi_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/CHEBI_138157"},{"id":"A81","pred":"chebi_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A82","pred":"chebi_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A83","pred":"chebi_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A84","pred":"chebi_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A85","pred":"chebi_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A86","pred":"chebi_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A87","pred":"chebi_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A88","pred":"chebi_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A89","pred":"chebi_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A90","pred":"chebi_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A91","pred":"chebi_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/CHEBI_35224"},{"id":"A92","pred":"chebi_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/CHEBI_138154"},{"id":"A93","pred":"chebi_id","subj":"T93","obj":"http://purl.obolibrary.org/obo/CHEBI_138157"},{"id":"A94","pred":"chebi_id","subj":"T94","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A95","pred":"chebi_id","subj":"T94","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A96","pred":"chebi_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/CHEBI_138154"},{"id":"A97","pred":"chebi_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/CHEBI_138157"},{"id":"A98","pred":"chebi_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A99","pred":"chebi_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A100","pred":"chebi_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A101","pred":"chebi_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A102","pred":"chebi_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A103","pred":"chebi_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A104","pred":"chebi_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"},{"id":"A105","pred":"chebi_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/CHEBI_141424"},{"id":"A106","pred":"chebi_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/CHEBI_25573"},{"id":"A107","pred":"chebi_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/CHEBI_1224"},{"id":"A108","pred":"chebi_id","subj":"T108","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A109","pred":"chebi_id","subj":"T108","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A110","pred":"chebi_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A111","pred":"chebi_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A112","pred":"chebi_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A113","pred":"chebi_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A114","pred":"chebi_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A115","pred":"chebi_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A116","pred":"chebi_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A117","pred":"chebi_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A118","pred":"chebi_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A119","pred":"chebi_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A120","pred":"chebi_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A121","pred":"chebi_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A122","pred":"chebi_id","subj":"T122","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A123","pred":"chebi_id","subj":"T122","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A124","pred":"chebi_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"},{"id":"A125","pred":"chebi_id","subj":"T125","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"},{"id":"A126","pred":"chebi_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/CHEBI_3478"},{"id":"A127","pred":"chebi_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/CHEBI_52214"},{"id":"A128","pred":"chebi_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/CHEBI_52214"},{"id":"A129","pred":"chebi_id","subj":"T129","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A130","pred":"chebi_id","subj":"T130","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"},{"id":"A131","pred":"chebi_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A132","pred":"chebi_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A133","pred":"chebi_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A134","pred":"chebi_id","subj":"T134","obj":"http://purl.obolibrary.org/obo/CHEBI_141424"},{"id":"A135","pred":"chebi_id","subj":"T134","obj":"http://purl.obolibrary.org/obo/CHEBI_25573"},{"id":"A136","pred":"chebi_id","subj":"T134","obj":"http://purl.obolibrary.org/obo/CHEBI_1224"},{"id":"A137","pred":"chebi_id","subj":"T137","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A138","pred":"chebi_id","subj":"T138","obj":"http://purl.obolibrary.org/obo/CHEBI_30212"},{"id":"A139","pred":"chebi_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/CHEBI_33385"}],"text":"Both ILC2 and γδ T cells are centrally involved in lung homoeostasis and are rapidly activated in response to pathogens including viruses;19, 21 in COVID-19, IL-4 is upregulated at early stages and in milder forms of the disease,10 whereas IL-9 and activated γδ T cells are observed more frequently in mild-to-moderate disease,9, 22 and IFNγ and IL-17 progressively increase with disease severity.6 Vγ9Vδ2+ T cells from patients with COVID-19 have been found to express an effector memory phenotype three times more frequently than do conventional αβ T cells,23 thus suggesting that this T cell subset is selectively stimulated in COVID-19. Because of significantly higher expression of the chemokine receptor CXCR3 compared with their αβ counterparts,24 γδ T cells might be rapidly recruited into inflamed lungs of patients with COVID-19 in response to the observed strong upregulation of the CXCR3 ligands CXCL9 and CXCL10 (figure 1 ).6, 9, 11, 15, 25, 26, 27, 28\nFigure 1 T-cell polarisation in COVID-19\nIL-33 released from virus-damaged cells might induce dysregulated GATA3+Foxp3+ Tregs and promote IL-2 production by dendritic cells, resulting in further expansion of Tregs. IL-33 might also elicit differentiation of ILC2, with TGFβ enhancing ST2 expression on these cells and facilitating production of IL-9. IL-9 in turn stimulates expansion of effector memory Vγ9Vδ2+ T cells with mixed Th1 and Th17 profiles that express CXCR3 and are recruited to the lungs by CXCL9 and CXCL10. IL-9 possibly induces its own transcription factor PU.1 and thus act in an autocrine and paracrine manner (along with TGFβ) to drive proliferation and survival of ILC2 and γδ T cells. Additional positive loops might be fed by IFNγ, which triggers production of CXCL9 and CXCL10 by macrophages. In severe forms of COVID-19, IL-33, along with IL-2 and IL-7 released by dendritic cells, might further stimulate T-cell expansion through STAT5 and induce production of large amounts of GM-CSF by γδ and T helper cells. At advanced stages of disease, aberrant activation of the MyD88-related NF-κB pathway and activation of the NLRP3 inflammasome might induce virus-exposed cells and infiltrating monocytes–macrophages to overproduce IL-1β, IL-23, and IL-6. IL-1β, IL-23, IL-6, and IL-7 act on STAT3 and RORC, thus promoting differentiation of CCR2+ T cells that are recruited to the lungs by CCL2 and CCL8 into γδT17 and Th17 cells producing IL-17 and GM-CSF. In turn, GM-CSF might further recruit and activate proinflammatory monocytes–macrophages. CCR=C-C motif chemokine receptor. CCL=C-C motif chemokine ligand. CXCL=C-X-C motif chemokine ligand. CXCR=C-X-C chemokine receptor. Foxp=forkhead box protein. GATA=GATA-binding factor. GM-CSF=granulocyte-macrophage colony-stimulating factor. IL=interleukin. ILC2=type 2 innate lymphoid cell. MyD88=myeloid differentiation primary response protein. NF-κB=nuclear factor-kappa B. NLRP=NACHT, LRR, and PYD domains-containing protein. PU.1=transcription factor PU.1. RORC=nuclear receptor ROR-gamma. ST2=ST2 receptor. STAT=signal transducer and transcription activator. TGF=transforming growth factor. Th=T-helper. TLR=toll-like receptors. Treg=regulatory T cell."}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T15","span":{"begin":482,"end":488},"obj":"http://purl.obolibrary.org/obo/GO_0007613"},{"id":"T16","span":{"begin":1104,"end":1119},"obj":"http://purl.obolibrary.org/obo/GO_0032623"},{"id":"T17","span":{"begin":1363,"end":1369},"obj":"http://purl.obolibrary.org/obo/GO_0007613"},{"id":"T18","span":{"begin":1520,"end":1540},"obj":"http://purl.obolibrary.org/obo/GO_0000981"},{"id":"T19","span":{"begin":1520,"end":1533},"obj":"http://purl.obolibrary.org/obo/GO_0006351"},{"id":"T20","span":{"begin":1900,"end":1914},"obj":"http://purl.obolibrary.org/obo/GO_0016049"},{"id":"T21","span":{"begin":2971,"end":2991},"obj":"http://purl.obolibrary.org/obo/GO_0000981"},{"id":"T22","span":{"begin":2971,"end":2984},"obj":"http://purl.obolibrary.org/obo/GO_0006351"},{"id":"T23","span":{"begin":3076,"end":3089},"obj":"http://purl.obolibrary.org/obo/GO_0006351"},{"id":"T24","span":{"begin":3118,"end":3124},"obj":"http://purl.obolibrary.org/obo/GO_0040007"}],"text":"Both ILC2 and γδ T cells are centrally involved in lung homoeostasis and are rapidly activated in response to pathogens including viruses;19, 21 in COVID-19, IL-4 is upregulated at early stages and in milder forms of the disease,10 whereas IL-9 and activated γδ T cells are observed more frequently in mild-to-moderate disease,9, 22 and IFNγ and IL-17 progressively increase with disease severity.6 Vγ9Vδ2+ T cells from patients with COVID-19 have been found to express an effector memory phenotype three times more frequently than do conventional αβ T cells,23 thus suggesting that this T cell subset is selectively stimulated in COVID-19. Because of significantly higher expression of the chemokine receptor CXCR3 compared with their αβ counterparts,24 γδ T cells might be rapidly recruited into inflamed lungs of patients with COVID-19 in response to the observed strong upregulation of the CXCR3 ligands CXCL9 and CXCL10 (figure 1 ).6, 9, 11, 15, 25, 26, 27, 28\nFigure 1 T-cell polarisation in COVID-19\nIL-33 released from virus-damaged cells might induce dysregulated GATA3+Foxp3+ Tregs and promote IL-2 production by dendritic cells, resulting in further expansion of Tregs. IL-33 might also elicit differentiation of ILC2, with TGFβ enhancing ST2 expression on these cells and facilitating production of IL-9. IL-9 in turn stimulates expansion of effector memory Vγ9Vδ2+ T cells with mixed Th1 and Th17 profiles that express CXCR3 and are recruited to the lungs by CXCL9 and CXCL10. IL-9 possibly induces its own transcription factor PU.1 and thus act in an autocrine and paracrine manner (along with TGFβ) to drive proliferation and survival of ILC2 and γδ T cells. Additional positive loops might be fed by IFNγ, which triggers production of CXCL9 and CXCL10 by macrophages. In severe forms of COVID-19, IL-33, along with IL-2 and IL-7 released by dendritic cells, might further stimulate T-cell expansion through STAT5 and induce production of large amounts of GM-CSF by γδ and T helper cells. At advanced stages of disease, aberrant activation of the MyD88-related NF-κB pathway and activation of the NLRP3 inflammasome might induce virus-exposed cells and infiltrating monocytes–macrophages to overproduce IL-1β, IL-23, and IL-6. IL-1β, IL-23, IL-6, and IL-7 act on STAT3 and RORC, thus promoting differentiation of CCR2+ T cells that are recruited to the lungs by CCL2 and CCL8 into γδT17 and Th17 cells producing IL-17 and GM-CSF. In turn, GM-CSF might further recruit and activate proinflammatory monocytes–macrophages. CCR=C-C motif chemokine receptor. CCL=C-C motif chemokine ligand. CXCL=C-X-C motif chemokine ligand. CXCR=C-X-C chemokine receptor. Foxp=forkhead box protein. GATA=GATA-binding factor. GM-CSF=granulocyte-macrophage colony-stimulating factor. IL=interleukin. ILC2=type 2 innate lymphoid cell. MyD88=myeloid differentiation primary response protein. NF-κB=nuclear factor-kappa B. NLRP=NACHT, LRR, and PYD domains-containing protein. PU.1=transcription factor PU.1. RORC=nuclear receptor ROR-gamma. ST2=ST2 receptor. STAT=signal transducer and transcription activator. TGF=transforming growth factor. Th=T-helper. TLR=toll-like receptors. Treg=regulatory T cell."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T22","span":{"begin":0,"end":640},"obj":"Sentence"},{"id":"T23","span":{"begin":641,"end":965},"obj":"Sentence"},{"id":"T24","span":{"begin":966,"end":1006},"obj":"Sentence"},{"id":"T25","span":{"begin":1007,"end":1180},"obj":"Sentence"},{"id":"T26","span":{"begin":1181,"end":1316},"obj":"Sentence"},{"id":"T27","span":{"begin":1317,"end":1489},"obj":"Sentence"},{"id":"T28","span":{"begin":1490,"end":1673},"obj":"Sentence"},{"id":"T29","span":{"begin":1674,"end":1783},"obj":"Sentence"},{"id":"T30","span":{"begin":1784,"end":2003},"obj":"Sentence"},{"id":"T31","span":{"begin":2004,"end":2241},"obj":"Sentence"},{"id":"T32","span":{"begin":2242,"end":2444},"obj":"Sentence"},{"id":"T33","span":{"begin":2445,"end":2534},"obj":"Sentence"},{"id":"T34","span":{"begin":2535,"end":2568},"obj":"Sentence"},{"id":"T35","span":{"begin":2569,"end":2600},"obj":"Sentence"},{"id":"T36","span":{"begin":2601,"end":2635},"obj":"Sentence"},{"id":"T37","span":{"begin":2636,"end":2666},"obj":"Sentence"},{"id":"T38","span":{"begin":2667,"end":2693},"obj":"Sentence"},{"id":"T39","span":{"begin":2694,"end":2719},"obj":"Sentence"},{"id":"T40","span":{"begin":2720,"end":2776},"obj":"Sentence"},{"id":"T41","span":{"begin":2777,"end":2792},"obj":"Sentence"},{"id":"T42","span":{"begin":2793,"end":2826},"obj":"Sentence"},{"id":"T43","span":{"begin":2827,"end":2882},"obj":"Sentence"},{"id":"T44","span":{"begin":2883,"end":2912},"obj":"Sentence"},{"id":"T45","span":{"begin":2913,"end":2965},"obj":"Sentence"},{"id":"T46","span":{"begin":2966,"end":2997},"obj":"Sentence"},{"id":"T47","span":{"begin":2998,"end":3030},"obj":"Sentence"},{"id":"T48","span":{"begin":3031,"end":3048},"obj":"Sentence"},{"id":"T49","span":{"begin":3049,"end":3100},"obj":"Sentence"},{"id":"T50","span":{"begin":3101,"end":3132},"obj":"Sentence"},{"id":"T51","span":{"begin":3133,"end":3145},"obj":"Sentence"},{"id":"T52","span":{"begin":3146,"end":3170},"obj":"Sentence"},{"id":"T53","span":{"begin":3171,"end":3194},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Both ILC2 and γδ T cells are centrally involved in lung homoeostasis and are rapidly activated in response to pathogens including viruses;19, 21 in COVID-19, IL-4 is upregulated at early stages and in milder forms of the disease,10 whereas IL-9 and activated γδ T cells are observed more frequently in mild-to-moderate disease,9, 22 and IFNγ and IL-17 progressively increase with disease severity.6 Vγ9Vδ2+ T cells from patients with COVID-19 have been found to express an effector memory phenotype three times more frequently than do conventional αβ T cells,23 thus suggesting that this T cell subset is selectively stimulated in COVID-19. Because of significantly higher expression of the chemokine receptor CXCR3 compared with their αβ counterparts,24 γδ T cells might be rapidly recruited into inflamed lungs of patients with COVID-19 in response to the observed strong upregulation of the CXCR3 ligands CXCL9 and CXCL10 (figure 1 ).6, 9, 11, 15, 25, 26, 27, 28\nFigure 1 T-cell polarisation in COVID-19\nIL-33 released from virus-damaged cells might induce dysregulated GATA3+Foxp3+ Tregs and promote IL-2 production by dendritic cells, resulting in further expansion of Tregs. IL-33 might also elicit differentiation of ILC2, with TGFβ enhancing ST2 expression on these cells and facilitating production of IL-9. IL-9 in turn stimulates expansion of effector memory Vγ9Vδ2+ T cells with mixed Th1 and Th17 profiles that express CXCR3 and are recruited to the lungs by CXCL9 and CXCL10. IL-9 possibly induces its own transcription factor PU.1 and thus act in an autocrine and paracrine manner (along with TGFβ) to drive proliferation and survival of ILC2 and γδ T cells. Additional positive loops might be fed by IFNγ, which triggers production of CXCL9 and CXCL10 by macrophages. In severe forms of COVID-19, IL-33, along with IL-2 and IL-7 released by dendritic cells, might further stimulate T-cell expansion through STAT5 and induce production of large amounts of GM-CSF by γδ and T helper cells. At advanced stages of disease, aberrant activation of the MyD88-related NF-κB pathway and activation of the NLRP3 inflammasome might induce virus-exposed cells and infiltrating monocytes–macrophages to overproduce IL-1β, IL-23, and IL-6. IL-1β, IL-23, IL-6, and IL-7 act on STAT3 and RORC, thus promoting differentiation of CCR2+ T cells that are recruited to the lungs by CCL2 and CCL8 into γδT17 and Th17 cells producing IL-17 and GM-CSF. In turn, GM-CSF might further recruit and activate proinflammatory monocytes–macrophages. CCR=C-C motif chemokine receptor. CCL=C-C motif chemokine ligand. CXCL=C-X-C motif chemokine ligand. CXCR=C-X-C chemokine receptor. Foxp=forkhead box protein. GATA=GATA-binding factor. GM-CSF=granulocyte-macrophage colony-stimulating factor. IL=interleukin. ILC2=type 2 innate lymphoid cell. MyD88=myeloid differentiation primary response protein. NF-κB=nuclear factor-kappa B. NLRP=NACHT, LRR, and PYD domains-containing protein. PU.1=transcription factor PU.1. RORC=nuclear receptor ROR-gamma. ST2=ST2 receptor. STAT=signal transducer and transcription activator. TGF=transforming growth factor. Th=T-helper. TLR=toll-like receptors. Treg=regulatory T cell."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"241","span":{"begin":998,"end":1006},"obj":"Disease"},{"id":"293","span":{"begin":1007,"end":1012},"obj":"Gene"},{"id":"294","span":{"begin":1073,"end":1078},"obj":"Gene"},{"id":"295","span":{"begin":1079,"end":1084},"obj":"Gene"},{"id":"296","span":{"begin":1104,"end":1108},"obj":"Gene"},{"id":"297","span":{"begin":1181,"end":1186},"obj":"Gene"},{"id":"298","span":{"begin":1235,"end":1239},"obj":"Gene"},{"id":"299","span":{"begin":1250,"end":1253},"obj":"Gene"},{"id":"300","span":{"begin":1311,"end":1315},"obj":"Gene"},{"id":"301","span":{"begin":1317,"end":1321},"obj":"Gene"},{"id":"302","span":{"begin":1432,"end":1437},"obj":"Gene"},{"id":"303","span":{"begin":1472,"end":1477},"obj":"Gene"},{"id":"304","span":{"begin":1482,"end":1488},"obj":"Gene"},{"id":"305","span":{"begin":1490,"end":1494},"obj":"Gene"},{"id":"306","span":{"begin":1541,"end":1545},"obj":"Gene"},{"id":"307","span":{"begin":1608,"end":1612},"obj":"Gene"},{"id":"308","span":{"begin":1716,"end":1720},"obj":"Gene"},{"id":"309","span":{"begin":1751,"end":1756},"obj":"Gene"},{"id":"310","span":{"begin":1761,"end":1767},"obj":"Gene"},{"id":"311","span":{"begin":1813,"end":1818},"obj":"Gene"},{"id":"312","span":{"begin":1831,"end":1835},"obj":"Gene"},{"id":"313","span":{"begin":1840,"end":1844},"obj":"Gene"},{"id":"314","span":{"begin":1923,"end":1928},"obj":"Gene"},{"id":"315","span":{"begin":1971,"end":1977},"obj":"Gene"},{"id":"316","span":{"begin":2062,"end":2067},"obj":"Gene"},{"id":"317","span":{"begin":2076,"end":2081},"obj":"Gene"},{"id":"318","span":{"begin":2112,"end":2117},"obj":"Gene"},{"id":"319","span":{"begin":2218,"end":2223},"obj":"Gene"},{"id":"320","span":{"begin":2225,"end":2230},"obj":"Gene"},{"id":"321","span":{"begin":2236,"end":2240},"obj":"Gene"},{"id":"322","span":{"begin":2242,"end":2247},"obj":"Gene"},{"id":"323","span":{"begin":2249,"end":2254},"obj":"Gene"},{"id":"324","span":{"begin":2256,"end":2260},"obj":"Gene"},{"id":"325","span":{"begin":2266,"end":2270},"obj":"Gene"},{"id":"326","span":{"begin":2278,"end":2283},"obj":"Gene"},{"id":"327","span":{"begin":2328,"end":2332},"obj":"Gene"},{"id":"328","span":{"begin":2377,"end":2381},"obj":"Gene"},{"id":"329","span":{"begin":2386,"end":2390},"obj":"Gene"},{"id":"330","span":{"begin":2427,"end":2432},"obj":"Gene"},{"id":"331","span":{"begin":2437,"end":2443},"obj":"Gene"},{"id":"332","span":{"begin":2454,"end":2460},"obj":"Gene"},{"id":"333","span":{"begin":2694,"end":2718},"obj":"Gene"},{"id":"334","span":{"begin":2827,"end":2832},"obj":"Gene"},{"id":"335","span":{"begin":2992,"end":2996},"obj":"Gene"},{"id":"336","span":{"begin":2918,"end":2923},"obj":"Gene"},{"id":"337","span":{"begin":2889,"end":2911},"obj":"Gene"},{"id":"338","span":{"begin":2883,"end":2888},"obj":"Gene"},{"id":"339","span":{"begin":2925,"end":2928},"obj":"Gene"},{"id":"340","span":{"begin":2966,"end":2970},"obj":"Gene"},{"id":"341","span":{"begin":1174,"end":1179},"obj":"Chemical"},{"id":"342","span":{"begin":2606,"end":2611},"obj":"Chemical"},{"id":"343","span":{"begin":1803,"end":1811},"obj":"Disease"},{"id":"360","span":{"begin":158,"end":162},"obj":"Gene"},{"id":"361","span":{"begin":240,"end":244},"obj":"Gene"},{"id":"362","span":{"begin":337,"end":341},"obj":"Gene"},{"id":"363","span":{"begin":346,"end":351},"obj":"Gene"},{"id":"364","span":{"begin":710,"end":715},"obj":"Gene"},{"id":"365","span":{"begin":894,"end":899},"obj":"Gene"},{"id":"366","span":{"begin":908,"end":913},"obj":"Gene"},{"id":"367","span":{"begin":918,"end":924},"obj":"Gene"},{"id":"368","span":{"begin":420,"end":428},"obj":"Species"},{"id":"369","span":{"begin":816,"end":824},"obj":"Species"},{"id":"370","span":{"begin":51,"end":68},"obj":"Disease"},{"id":"371","span":{"begin":148,"end":156},"obj":"Disease"},{"id":"372","span":{"begin":434,"end":442},"obj":"Disease"},{"id":"373","span":{"begin":548,"end":552},"obj":"Disease"},{"id":"374","span":{"begin":631,"end":639},"obj":"Disease"},{"id":"375","span":{"begin":830,"end":838},"obj":"Disease"}],"attributes":[{"id":"A241","pred":"tao:has_database_id","subj":"241","obj":"MESH:C000657245"},{"id":"A293","pred":"tao:has_database_id","subj":"293","obj":"Gene:90865"},{"id":"A294","pred":"tao:has_database_id","subj":"294","obj":"Gene:2625"},{"id":"A295","pred":"tao:has_database_id","subj":"295","obj":"Gene:50943"},{"id":"A296","pred":"tao:has_database_id","subj":"296","obj":"Gene:3558"},{"id":"A297","pred":"tao:has_database_id","subj":"297","obj":"Gene:90865"},{"id":"A298","pred":"tao:has_database_id","subj":"298","obj":"Gene:7039"},{"id":"A299","pred":"tao:has_database_id","subj":"299","obj":"Gene:6761"},{"id":"A300","pred":"tao:has_database_id","subj":"300","obj":"Gene:3578"},{"id":"A301","pred":"tao:has_database_id","subj":"301","obj":"Gene:3578"},{"id":"A302","pred":"tao:has_database_id","subj":"302","obj":"Gene:2833"},{"id":"A303","pred":"tao:has_database_id","subj":"303","obj":"Gene:4283"},{"id":"A304","pred":"tao:has_database_id","subj":"304","obj":"Gene:3627"},{"id":"A305","pred":"tao:has_database_id","subj":"305","obj":"Gene:3578"},{"id":"A306","pred":"tao:has_database_id","subj":"306","obj":"Gene:6688"},{"id":"A307","pred":"tao:has_database_id","subj":"307","obj":"Gene:7039"},{"id":"A308","pred":"tao:has_database_id","subj":"308","obj":"Gene:3458"},{"id":"A309","pred":"tao:has_database_id","subj":"309","obj":"Gene:4283"},{"id":"A310","pred":"tao:has_database_id","subj":"310","obj":"Gene:3627"},{"id":"A311","pred":"tao:has_database_id","subj":"311","obj":"Gene:90865"},{"id":"A312","pred":"tao:has_database_id","subj":"312","obj":"Gene:3558"},{"id":"A313","pred":"tao:has_database_id","subj":"313","obj":"Gene:3574"},{"id":"A314","pred":"tao:has_database_id","subj":"314","obj":"Gene:6776"},{"id":"A315","pred":"tao:has_database_id","subj":"315","obj":"Gene:1437"},{"id":"A316","pred":"tao:has_database_id","subj":"316","obj":"Gene:4615"},{"id":"A317","pred":"tao:has_database_id","subj":"317","obj":"Gene:4790"},{"id":"A318","pred":"tao:has_database_id","subj":"318","obj":"Gene:114548"},{"id":"A319","pred":"tao:has_database_id","subj":"319","obj":"Gene:3552"},{"id":"A320","pred":"tao:has_database_id","subj":"320","obj":"Gene:51561"},{"id":"A321","pred":"tao:has_database_id","subj":"321","obj":"Gene:3569"},{"id":"A322","pred":"tao:has_database_id","subj":"322","obj":"Gene:3552"},{"id":"A323","pred":"tao:has_database_id","subj":"323","obj":"Gene:51561"},{"id":"A324","pred":"tao:has_database_id","subj":"324","obj":"Gene:3569"},{"id":"A325","pred":"tao:has_database_id","subj":"325","obj":"Gene:3574"},{"id":"A326","pred":"tao:has_database_id","subj":"326","obj":"Gene:6774"},{"id":"A327","pred":"tao:has_database_id","subj":"327","obj":"Gene:729230"},{"id":"A328","pred":"tao:has_database_id","subj":"328","obj":"Gene:6347"},{"id":"A329","pred":"tao:has_database_id","subj":"329","obj":"Gene:6355"},{"id":"A330","pred":"tao:has_database_id","subj":"330","obj":"Gene:3605"},{"id":"A331","pred":"tao:has_database_id","subj":"331","obj":"Gene:1437"},{"id":"A332","pred":"tao:has_database_id","subj":"332","obj":"Gene:1437"},{"id":"A333","pred":"tao:has_database_id","subj":"333","obj":"Gene:55278"},{"id":"A334","pred":"tao:has_database_id","subj":"334","obj":"Gene:4615"},{"id":"A335","pred":"tao:has_database_id","subj":"335","obj":"Gene:6688"},{"id":"A336","pred":"tao:has_database_id","subj":"336","obj":"Gene:114548"},{"id":"A337","pred":"tao:has_database_id","subj":"337","obj":"Gene:4790"},{"id":"A338","pred":"tao:has_database_id","subj":"338","obj":"Gene:4790"},{"id":"A339","pred":"tao:has_database_id","subj":"339","obj":"Gene:114548"},{"id":"A340","pred":"tao:has_database_id","subj":"340","obj":"Gene:6688"},{"id":"A343","pred":"tao:has_database_id","subj":"343","obj":"MESH:C000657245"},{"id":"A360","pred":"tao:has_database_id","subj":"360","obj":"Gene:3565"},{"id":"A361","pred":"tao:has_database_id","subj":"361","obj":"Gene:3578"},{"id":"A362","pred":"tao:has_database_id","subj":"362","obj":"Gene:3458"},{"id":"A363","pred":"tao:has_database_id","subj":"363","obj":"Gene:3605"},{"id":"A364","pred":"tao:has_database_id","subj":"364","obj":"Gene:2833"},{"id":"A365","pred":"tao:has_database_id","subj":"365","obj":"Gene:2833"},{"id":"A366","pred":"tao:has_database_id","subj":"366","obj":"Gene:4283"},{"id":"A367","pred":"tao:has_database_id","subj":"367","obj":"Gene:3627"},{"id":"A368","pred":"tao:has_database_id","subj":"368","obj":"Tax:9606"},{"id":"A369","pred":"tao:has_database_id","subj":"369","obj":"Tax:9606"},{"id":"A370","pred":"tao:has_database_id","subj":"370","obj":"MESH:D008171"},{"id":"A371","pred":"tao:has_database_id","subj":"371","obj":"MESH:C000657245"},{"id":"A372","pred":"tao:has_database_id","subj":"372","obj":"MESH:C000657245"},{"id":"A373","pred":"tao:has_database_id","subj":"373","obj":"MESH:D001260"},{"id":"A374","pred":"tao:has_database_id","subj":"374","obj":"MESH:C000657245"},{"id":"A375","pred":"tao:has_database_id","subj":"375","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Both ILC2 and γδ T cells are centrally involved in lung homoeostasis and are rapidly activated in response to pathogens including viruses;19, 21 in COVID-19, IL-4 is upregulated at early stages and in milder forms of the disease,10 whereas IL-9 and activated γδ T cells are observed more frequently in mild-to-moderate disease,9, 22 and IFNγ and IL-17 progressively increase with disease severity.6 Vγ9Vδ2+ T cells from patients with COVID-19 have been found to express an effector memory phenotype three times more frequently than do conventional αβ T cells,23 thus suggesting that this T cell subset is selectively stimulated in COVID-19. Because of significantly higher expression of the chemokine receptor CXCR3 compared with their αβ counterparts,24 γδ T cells might be rapidly recruited into inflamed lungs of patients with COVID-19 in response to the observed strong upregulation of the CXCR3 ligands CXCL9 and CXCL10 (figure 1 ).6, 9, 11, 15, 25, 26, 27, 28\nFigure 1 T-cell polarisation in COVID-19\nIL-33 released from virus-damaged cells might induce dysregulated GATA3+Foxp3+ Tregs and promote IL-2 production by dendritic cells, resulting in further expansion of Tregs. IL-33 might also elicit differentiation of ILC2, with TGFβ enhancing ST2 expression on these cells and facilitating production of IL-9. IL-9 in turn stimulates expansion of effector memory Vγ9Vδ2+ T cells with mixed Th1 and Th17 profiles that express CXCR3 and are recruited to the lungs by CXCL9 and CXCL10. IL-9 possibly induces its own transcription factor PU.1 and thus act in an autocrine and paracrine manner (along with TGFβ) to drive proliferation and survival of ILC2 and γδ T cells. Additional positive loops might be fed by IFNγ, which triggers production of CXCL9 and CXCL10 by macrophages. In severe forms of COVID-19, IL-33, along with IL-2 and IL-7 released by dendritic cells, might further stimulate T-cell expansion through STAT5 and induce production of large amounts of GM-CSF by γδ and T helper cells. At advanced stages of disease, aberrant activation of the MyD88-related NF-κB pathway and activation of the NLRP3 inflammasome might induce virus-exposed cells and infiltrating monocytes–macrophages to overproduce IL-1β, IL-23, and IL-6. IL-1β, IL-23, IL-6, and IL-7 act on STAT3 and RORC, thus promoting differentiation of CCR2+ T cells that are recruited to the lungs by CCL2 and CCL8 into γδT17 and Th17 cells producing IL-17 and GM-CSF. In turn, GM-CSF might further recruit and activate proinflammatory monocytes–macrophages. CCR=C-C motif chemokine receptor. CCL=C-C motif chemokine ligand. CXCL=C-X-C motif chemokine ligand. CXCR=C-X-C chemokine receptor. Foxp=forkhead box protein. GATA=GATA-binding factor. GM-CSF=granulocyte-macrophage colony-stimulating factor. IL=interleukin. ILC2=type 2 innate lymphoid cell. MyD88=myeloid differentiation primary response protein. NF-κB=nuclear factor-kappa B. NLRP=NACHT, LRR, and PYD domains-containing protein. PU.1=transcription factor PU.1. RORC=nuclear receptor ROR-gamma. ST2=ST2 receptor. STAT=signal transducer and transcription activator. TGF=transforming growth factor. Th=T-helper. TLR=toll-like receptors. Treg=regulatory T cell."}
2_test
{"project":"2_test","denotations":[{"id":"33073244-27543964-66244526","span":{"begin":138,"end":140},"obj":"27543964"},{"id":"33073244-28555812-66244527","span":{"begin":142,"end":144},"obj":"28555812"},{"id":"33073244-32460357-66244528","span":{"begin":229,"end":231},"obj":"32460357"},{"id":"33073244-31986264-66244529","span":{"begin":327,"end":328},"obj":"31986264"},{"id":"33073244-32467616-66244530","span":{"begin":559,"end":561},"obj":"32467616"},{"id":"33073244-11994442-66244531","span":{"begin":752,"end":754},"obj":"11994442"},{"id":"33073244-31986264-66244532","span":{"begin":940,"end":941},"obj":"31986264"},{"id":"33073244-32228226-66244533","span":{"begin":943,"end":945},"obj":"32228226"},{"id":"33073244-32398875-66244534","span":{"begin":947,"end":949},"obj":"32398875"},{"id":"33073244-32360286-66244535","span":{"begin":951,"end":953},"obj":"32360286"},{"id":"33073244-32407669-66244536","span":{"begin":955,"end":957},"obj":"32407669"},{"id":"33073244-32416070-66244537","span":{"begin":959,"end":961},"obj":"32416070"}],"text":"Both ILC2 and γδ T cells are centrally involved in lung homoeostasis and are rapidly activated in response to pathogens including viruses;19, 21 in COVID-19, IL-4 is upregulated at early stages and in milder forms of the disease,10 whereas IL-9 and activated γδ T cells are observed more frequently in mild-to-moderate disease,9, 22 and IFNγ and IL-17 progressively increase with disease severity.6 Vγ9Vδ2+ T cells from patients with COVID-19 have been found to express an effector memory phenotype three times more frequently than do conventional αβ T cells,23 thus suggesting that this T cell subset is selectively stimulated in COVID-19. Because of significantly higher expression of the chemokine receptor CXCR3 compared with their αβ counterparts,24 γδ T cells might be rapidly recruited into inflamed lungs of patients with COVID-19 in response to the observed strong upregulation of the CXCR3 ligands CXCL9 and CXCL10 (figure 1 ).6, 9, 11, 15, 25, 26, 27, 28\nFigure 1 T-cell polarisation in COVID-19\nIL-33 released from virus-damaged cells might induce dysregulated GATA3+Foxp3+ Tregs and promote IL-2 production by dendritic cells, resulting in further expansion of Tregs. IL-33 might also elicit differentiation of ILC2, with TGFβ enhancing ST2 expression on these cells and facilitating production of IL-9. IL-9 in turn stimulates expansion of effector memory Vγ9Vδ2+ T cells with mixed Th1 and Th17 profiles that express CXCR3 and are recruited to the lungs by CXCL9 and CXCL10. IL-9 possibly induces its own transcription factor PU.1 and thus act in an autocrine and paracrine manner (along with TGFβ) to drive proliferation and survival of ILC2 and γδ T cells. Additional positive loops might be fed by IFNγ, which triggers production of CXCL9 and CXCL10 by macrophages. In severe forms of COVID-19, IL-33, along with IL-2 and IL-7 released by dendritic cells, might further stimulate T-cell expansion through STAT5 and induce production of large amounts of GM-CSF by γδ and T helper cells. At advanced stages of disease, aberrant activation of the MyD88-related NF-κB pathway and activation of the NLRP3 inflammasome might induce virus-exposed cells and infiltrating monocytes–macrophages to overproduce IL-1β, IL-23, and IL-6. IL-1β, IL-23, IL-6, and IL-7 act on STAT3 and RORC, thus promoting differentiation of CCR2+ T cells that are recruited to the lungs by CCL2 and CCL8 into γδT17 and Th17 cells producing IL-17 and GM-CSF. In turn, GM-CSF might further recruit and activate proinflammatory monocytes–macrophages. CCR=C-C motif chemokine receptor. CCL=C-C motif chemokine ligand. CXCL=C-X-C motif chemokine ligand. CXCR=C-X-C chemokine receptor. Foxp=forkhead box protein. GATA=GATA-binding factor. GM-CSF=granulocyte-macrophage colony-stimulating factor. IL=interleukin. ILC2=type 2 innate lymphoid cell. MyD88=myeloid differentiation primary response protein. NF-κB=nuclear factor-kappa B. NLRP=NACHT, LRR, and PYD domains-containing protein. PU.1=transcription factor PU.1. RORC=nuclear receptor ROR-gamma. ST2=ST2 receptor. STAT=signal transducer and transcription activator. TGF=transforming growth factor. Th=T-helper. TLR=toll-like receptors. Treg=regulatory T cell."}